TempraMed signs LOI for exclusive Greece distribution of VIVI products
TempraMed Technologies Ltd. signed a letter of intent with CPO Greece for an exclusive distribution framework covering TempraMed’s injectable medication-protection products across Greece, linked to VIVI products.
Distribution framework pairs TempraMed's injectable medication-protection products with one of the largest, most established Greek pharmacy and healthcare distributorsHighlights:Toronto, Ontario--(. - September 1, 2026) - TempraMed Technologies Ltd.
CSE:VIVI (FSE: 9DY) (OTCQB: TMPTF…